Skip to content

To Study The Effect Of Kushthaghana Mahakashaya And Khadir-Triphaladi Kashaya In The Management Of Ek-Kushtha With Special Reference To Plaque Psoriasis

A Randomized Open Labelled Comparative Clinical Study To Evaluate The Efficacy Of Kushthaghana Mahakashaya And Khadir-Triphaladi Kashaya In The Management Of Ek-Kushtha With Special Reference To Plaque Psoriasis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100927
Enrollment
30
Registered
2026-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Sponsors

Jammu Institute Of Ayurveda And Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with classical features of Ek-Kushtha as per Ayurvedic texts and modern literature. 2. Patients aged between 16 and 60 years irrespective of gender. 3. Patients with a history of Ek-Kushtha less than two years.

Exclusion criteria

Exclusion criteria: 1. Age below 16 years and above 60 years. 2. Skin disorders other than Ek-Kushtha shall be excluded. 3. Patients with systemic disorders like cardiac illness, bronchial asthma, or endocrine disorders that may interfere with the treatment will be excluded. 4. Pregnant and lactating women. 5. Chronicity of disease for more than two years. 6. Patients who have undergone recent surgeries. 7. Patients on oral corticosteroid therapy.

Design outcomes

Primary

MeasureTime frame
Improvement in subjective and objective parameters of Ek-Kushtha (Plaque Psoriasis): Subjective: Matsyashakalopamam, Kandu, Rukshatva Objective: Auspitz s Sign, Candle Grease Sign Timepoint: Assessment: Percentage relief in symptoms and signs after 30 days of treatment.

Secondary

MeasureTime frame
Improvement in quality of life and prevention of recurrence. Improvement in laboratory findings (Hb%, ESR, Blood Sugar)Timepoint: Follow-up evaluation at 15th, 30th, and 45th day (including drug-free follow-up).

Countries

India

Contacts

Public ContactDr Shubham Sharma

Jammu Institute Of Ayurveda And Research

Dr.nitinmahajan1608@gmail.com9419119123

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026